Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. (2022)

First Author: Toback S

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00409-4

PubMed Identifier: 34800364

Publication URI: http://europepmc.org/abstract/MED/34800364

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Respiratory medicine

Issue: 2

ISSN: 2213-2600